Logo image of CRRX.CA

CARERX CORP (CRRX.CA) Stock Fundamental Analysis

TSX:CRRX - Toronto Stock Exchange - CA14173C1059 - Common Stock - Currency: CAD

2.85  -0.01 (-0.35%)

Fundamental Rating

4

Overall CRRX gets a fundamental rating of 4 out of 10. We evaluated CRRX against 16 industry peers in the Consumer Staples Distribution & Retail industry. The financial health of CRRX is average, but there are quite some concerns on its profitability. CRRX has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year CRRX has reported negative net income.
In the past year CRRX had a positive cash flow from operations.
CRRX had negative earnings in each of the past 5 years.
CRRX had a positive operating cash flow in each of the past 5 years.
CRRX.CA Yearly Net Income VS EBIT VS OCF VS FCFCRRX.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

1.2 Ratios

CRRX has a worse Return On Assets (-1.68%) than 81.25% of its industry peers.
CRRX has a Return On Equity of -4.35%. This is amonst the worse of the industry: CRRX underperforms 87.50% of its industry peers.
The Return On Invested Capital of CRRX (3.50%) is worse than 68.75% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CRRX is significantly below the industry average of 8.31%.
The last Return On Invested Capital (3.50%) for CRRX is above the 3 year average (3.05%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -1.68%
ROE -4.35%
ROIC 3.5%
ROA(3y)-5.78%
ROA(5y)-7.42%
ROE(3y)-21.76%
ROE(5y)-50.97%
ROIC(3y)3.05%
ROIC(5y)N/A
CRRX.CA Yearly ROA, ROE, ROICCRRX.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 -400 -600

1.3 Margins

With a Operating Margin value of 2.16%, CRRX is not doing good in the industry: 68.75% of the companies in the same industry are doing better.
In the last couple of years the Operating Margin of CRRX has grown nicely.
CRRX has a Gross Margin (29.53%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of CRRX has remained more or less at the same level.
Industry RankSector Rank
OM 2.16%
PM (TTM) N/A
GM 29.53%
OM growth 3Y3.53%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.93%
GM growth 5Y-1.4%
CRRX.CA Yearly Profit, Operating, Gross MarginsCRRX.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CRRX is destroying value.
Compared to 1 year ago, CRRX has more shares outstanding
Compared to 5 years ago, CRRX has more shares outstanding
Compared to 1 year ago, CRRX has an improved debt to assets ratio.
CRRX.CA Yearly Shares OutstandingCRRX.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
CRRX.CA Yearly Total Debt VS Total AssetsCRRX.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

CRRX has an Altman-Z score of 0.77. This is a bad value and indicates that CRRX is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of CRRX (0.77) is worse than 87.50% of its industry peers.
CRRX has a debt to FCF ratio of 3.00. This is a good value and a sign of high solvency as CRRX would need 3.00 years to pay back of all of its debts.
CRRX has a Debt to FCF ratio of 3.00. This is amongst the best in the industry. CRRX outperforms 93.75% of its industry peers.
A Debt/Equity ratio of 0.86 indicates that CRRX is somewhat dependend on debt financing.
The Debt to Equity ratio of CRRX (0.86) is better than 62.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.86
Debt/FCF 3
Altman-Z 0.77
ROIC/WACC0.52
WACC6.79%
CRRX.CA Yearly LT Debt VS Equity VS FCFCRRX.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M 250M

2.3 Liquidity

CRRX has a Current Ratio of 1.07. This is a normal value and indicates that CRRX is financially healthy and should not expect problems in meeting its short term obligations.
CRRX's Current ratio of 1.07 is on the low side compared to the rest of the industry. CRRX is outperformed by 75.00% of its industry peers.
A Quick Ratio of 0.76 indicates that CRRX may have some problems paying its short term obligations.
CRRX's Quick ratio of 0.76 is fine compared to the rest of the industry. CRRX outperforms 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.07
Quick Ratio 0.76
CRRX.CA Yearly Current Assets VS Current LiabilitesCRRX.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

4

3. Growth

3.1 Past

The earnings per share for CRRX have decreased by 0.00% in the last year.
Looking at the last year, CRRX shows a decrease in Revenue. The Revenue has decreased by -0.69% in the last year.
CRRX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 24.10% yearly.
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)-0.69%
Revenue growth 3Y11.77%
Revenue growth 5Y24.1%
Sales Q2Q%-0.2%

3.2 Future

CRRX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 31.92% yearly.
CRRX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.70% yearly.
EPS Next Y245.13%
EPS Next 2Y117.2%
EPS Next 3Y31.92%
EPS Next 5YN/A
Revenue Next Year2.34%
Revenue Next 2Y3.87%
Revenue Next 3Y2.7%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CRRX.CA Yearly Revenue VS EstimatesCRRX.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M
CRRX.CA Yearly EPS VS EstimatesCRRX.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -1 -2 -3

5

4. Valuation

4.1 Price/Earnings Ratio

CRRX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 14.98 indicates a correct valuation of CRRX.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CRRX is on the same level as its industry peers.
CRRX's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 36.52.
Industry RankSector Rank
PE N/A
Fwd PE 14.98
CRRX.CA Price Earnings VS Forward Price EarningsCRRX.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as CRRX.
Based on the Price/Free Cash Flow ratio, CRRX is valued a bit cheaper than the industry average as 68.75% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 6.53
EV/EBITDA 9.28
CRRX.CA Per share dataCRRX.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CRRX's earnings are expected to grow with 31.92% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y117.2%
EPS Next 3Y31.92%

0

5. Dividend

5.1 Amount

CRRX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CARERX CORP

TSX:CRRX (7/17/2025, 7:00:00 PM)

2.85

-0.01 (-0.35%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)05-07 2025-05-07/bmo
Earnings (Next)08-07 2025-08-07
Inst Owners53.54%
Inst Owner ChangeN/A
Ins Owners10.26%
Ins Owner ChangeN/A
Market Cap179.58M
Analysts80
Price Target3.86 (35.44%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-179.49%
Min EPS beat(2)-258.98%
Max EPS beat(2)-100%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.9%
Min Revenue beat(2)-3.67%
Max Revenue beat(2)-2.13%
Revenue beat(4)0
Avg Revenue beat(4)-1.68%
Min Revenue beat(4)-3.67%
Max Revenue beat(4)-0.38%
Revenue beat(8)0
Avg Revenue beat(8)-2.14%
Revenue beat(12)2
Avg Revenue beat(12)-1.85%
Revenue beat(16)4
Avg Revenue beat(16)-0.87%
PT rev (1m)0%
PT rev (3m)3.52%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.72%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 14.98
P/S 0.49
P/FCF 6.53
P/OCF 4.98
P/B 2.08
P/tB N/A
EV/EBITDA 9.28
EPS(TTM)-0.06
EYN/A
EPS(NY)0.19
Fwd EY6.67%
FCF(TTM)0.44
FCFY15.32%
OCF(TTM)0.57
OCFY20.1%
SpS5.82
BVpS1.37
TBVpS-0.25
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.68%
ROE -4.35%
ROCE 4.87%
ROIC 3.5%
ROICexc 3.76%
ROICexgc 11.55%
OM 2.16%
PM (TTM) N/A
GM 29.53%
FCFM 7.5%
ROA(3y)-5.78%
ROA(5y)-7.42%
ROE(3y)-21.76%
ROE(5y)-50.97%
ROIC(3y)3.05%
ROIC(5y)N/A
ROICexc(3y)3.31%
ROICexc(5y)N/A
ROICexgc(3y)11.1%
ROICexgc(5y)N/A
ROCE(3y)4.24%
ROCE(5y)N/A
ROICexcg growth 3Y15.88%
ROICexcg growth 5YN/A
ROICexc growth 3Y25.67%
ROICexc growth 5YN/A
OM growth 3Y3.53%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.93%
GM growth 5Y-1.4%
F-Score7
Asset Turnover1.64
Health
Industry RankSector Rank
Debt/Equity 0.86
Debt/FCF 3
Debt/EBITDA 2.75
Cap/Depr 44.86%
Cap/Sales 2.34%
Interest Coverage 1.25
Cash Conversion 133.43%
Profit Quality N/A
Current Ratio 1.07
Quick Ratio 0.76
Altman-Z 0.77
F-Score7
WACC6.79%
ROIC/WACC0.52
Cap/Depr(3y)51.22%
Cap/Depr(5y)43.4%
Cap/Sales(3y)2.71%
Cap/Sales(5y)2.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next Y245.13%
EPS Next 2Y117.2%
EPS Next 3Y31.92%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.69%
Revenue growth 3Y11.77%
Revenue growth 5Y24.1%
Sales Q2Q%-0.2%
Revenue Next Year2.34%
Revenue Next 2Y3.87%
Revenue Next 3Y2.7%
Revenue Next 5YN/A
EBIT growth 1Y-1.33%
EBIT growth 3Y15.72%
EBIT growth 5YN/A
EBIT Next Year370.62%
EBIT Next 3Y66.29%
EBIT Next 5YN/A
FCF growth 1Y69.85%
FCF growth 3Y480.16%
FCF growth 5Y59.88%
OCF growth 1Y26.29%
OCF growth 3Y73.54%
OCF growth 5Y42.97%